Discovery of natural product ellagic acid as a potent CD73 and CD39 dual inhibitor

Discovery of natural product ellagic acid as a potent CD73 and CD39 dual inhibitor Discovery and optimization of betulinic acid derivatives as novel potent CD73 inhibitors Targeting Metabolism of Extracellular Nucleotides via Inhibition of Ectonucleotidases CD73 and CD39 2-Substituted α,β-Methylene-ADP Derivatives: Potent Competitive Ecto-5′-nucleotidase (CD73) Inhibitors with Variable Binding Modes Discovery of potent nucleotide pyrophosphatase/phosphodiesterase3 (NPP3) inhibitors with ancillary carbonic anhydrase inhibition for cancer (immuno)therapy Identification of sulfonic acids as efficient ecto-5′-nucleotidase inhibitors Structure–Activity Relationship of Purine and Pyrimidine Nucleotides as Ecto-5′-Nucleotidase (CD73) Inhibitors Dual NAMPT/HDAC Inhibitors as a New Strategy for Multitargeting Antitumor Drug Discovery New hexahydroxybiphenyl derivatives as inhibitors of protein kinase C A Novel Bitriazolyl Acyclonucleoside Endowed with Dual Antiproliferative and Immunomodulatory Activity